In silico PK predictions in Drug Discovery: Benchmarking of Strategies to Integrate Machine Learning with Empiric and Mechanistic PK modelling
Preprint
Abstract
A successful drug needs to combine several properties including high potency and good pharmacokinetic (PK) properties to sustain efficacious plasma concentration over time. To estimate required doses for preclinical animal efficacy models or for the clinics, in vivo PK studies need to be conducted. While the prediction of ADME properties of compounds using Machine Learning (ML) models based on chemical structures is well established in drug discovery, the prediction of complete plasma concentration-time profiles has only recently gained attention. In this study, we systematically compare various approaches that integrate ML models with mechanistic PK models to predict PK profiles in rats after i.v. administration prior to synthesis. More specifically, we compare a standard noncompartmental analysis (NCA) based approach (prediction of CL and V ss ), a pure ML approach (non-mechanistic PK description), a compartmental modeling approach, and a physiologically based pharmacokinetic (PBPK) approach. Our study based on internal preclinical data shows that the latter three approaches yield PK profile predictions of comparable accuracy (evaluated as geometric mean fold errors for each profile) across a large test set (>1000 small molecules). In summary, we demonstrate the improved ability to prioritize drug candidates with desirable PK properties prior to synthesis with ML predictions.Keywords
All Related Versions
- Published version: Clinical and Translational Science, 18 (3), e70150.
This publication has 39 references indexed in Scilit:
- A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in HumansPharmaceutical Research, 2024
- A deep neural network: mechanistic hybrid model to predict pharmacokinetics in ratJournal of Computer-Aided Molecular Design, 2024
- Prediction of Human Pharmacokinetics From Chemical Structure: Combining Mechanistic Modeling with Machine LearningJournal of Pharmaceutical Sciences, 2023
- Towards holistic Compound Quality Scores: Extending ligand efficiency indices with compound pharmacokinetic characteristicsDrug Discovery Today, 2023
- Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compoundsBiopharmaceutics & Drug Disposition, 2023
- The area under the effect curve as an efficacy determinant for anti‐infectivesCPT: Pharmacometrics & Systems Pharmacology, 2022
- ADMET Predictability at Boehringer Ingelheim: State‐of‐the‐Art, and Do Bigger Datasets or Algorithms Make a Difference?Molecular Informatics, 2021
- alvaDesc: A Tool to Calculate and Analyze Molecular Descriptors and Fingerprints2020
- In silico pKa Prediction and ADME ProfilingChemistry & Biodiversity, 2009
- Ligand efficiency indices as guideposts for drug discoveryDrug Discovery Today, 2005